{"altmetric_id":4685777,"counts":{"readers":{"mendeley":13,"citeulike":0,"connotea":0},"total":{"posts_count":2},"twitter":{"unique_users_count":1,"unique_users":["RafHerrera77"],"posts_count":2}},"citation":{"altmetric_jid":"4f6fa4f73cf058f610002fd1","authors":["Bolla, Michel"],"doi":"10.1016\/s1470-2045(15)00364-2","first_seen_on":"2015-10-28T11:51:14+00:00","funders":["niehs"],"issns":["14702045","1474-5488"],"journal":"Lancet Oncology","last_mentioned_on":1446033405,"links":["http:\/\/www.thelancet.com\/journals\/lanonc\/article\/PIIS1470-2045(15)00364-2\/abstract"],"pdf_url":"http:\/\/www.thelancet.com\/article\/S1470204515003642\/pdf","pmid":"26522335","pubdate":"2015-11-03T22:00:58+00:00","publisher":"Elsevier","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"subjects":["neoplasms"],"title":"Hypofractionation for prostate cancer and PROs ","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/hypofractionation-prostate-cancer-pros"},"altmetric_score":{"score":1,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":1},"context_for_score":{"all":{"total_number_of_other_articles":6500718,"mean":6.0222432796255,"rank":3077371,"this_scored_higher_than_pct":29,"this_scored_higher_than":1943201,"rank_type":"exact","sample_size":6500718,"percentile":29},"similar_age_3m":{"total_number_of_other_articles":207323,"mean":10.262532929453,"rank":110940,"this_scored_higher_than_pct":36,"this_scored_higher_than":75317,"rank_type":"exact","sample_size":207323,"percentile":36},"this_journal":{"total_number_of_other_articles":3030,"mean":15.122907890393,"rank":2125,"this_scored_higher_than_pct":21,"this_scored_higher_than":643,"rank_type":"exact","sample_size":3030,"percentile":21},"similar_age_this_journal_3m":{"total_number_of_other_articles":93,"mean":39.948782608696,"rank":76,"this_scored_higher_than_pct":10,"this_scored_higher_than":10,"rank_type":"exact","sample_size":93,"percentile":10}}},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}},"mendeley":{"by_status":{"Unspecified":1,"Researcher":1,"Student  > Doctoral Student":2,"Student  > Postgraduate":2,"Student  > Master":4,"Other":1,"Lecturer":2},"by_discipline":{"Medicine and Dentistry":10,"Physics and Astronomy":1,"Biochemistry, Genetics and Molecular Biology":1,"Unspecified":1}}},"geo":{"twitter":{"DO":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/RafHerrera77\/statuses\/659336434143244288","license":"gnip","citation_ids":[4685777],"posted_on":"2015-10-28T11:50:30+00:00","author":{"name":"Rafael E Herrera","image":"https:\/\/pbs.twimg.com\/profile_images\/874742809630322690\/lqUNh1Xq_normal.jpg","description":"Onc\u00f3logo Radioter\u00e1pico en Instituto de Oncolog\u00eda Dr. Heriberto Pieter (IOHP\/LDCC) y CDD Radioterapia (Cl\u00ednica Abreu) Santo Domingo. Rep\u00fablica Dominicana.","id_on_source":"RafHerrera77","tweeter_id":"122140761","geo":{"lt":18.50012,"ln":-69.98857,"country":"DO"},"followers":225},"tweet_id":"659336434143244288"},{"url":"http:\/\/twitter.com\/RafHerrera77\/statuses\/659338006067703808","license":"gnip","citation_ids":[4685777],"posted_on":"2015-10-28T11:56:45+00:00","author":{"name":"Rafael E Herrera","image":"https:\/\/pbs.twimg.com\/profile_images\/874742809630322690\/lqUNh1Xq_normal.jpg","description":"Onc\u00f3logo Radioter\u00e1pico en Instituto de Oncolog\u00eda Dr. Heriberto Pieter (IOHP\/LDCC) y CDD Radioterapia (Cl\u00ednica Abreu) Santo Domingo. Rep\u00fablica Dominicana.","id_on_source":"RafHerrera77","tweeter_id":"122140761","geo":{"lt":18.50012,"ln":-69.98857,"country":"DO"},"followers":225},"tweet_id":"659338006067703808"}]}}